Towa Pharmaceutical Co Ltd is a leading company in the pharmaceutical industry. They are committed to delivering high-quality healthcare products and services to improve the well-being of people's lives. Towa Pharmaceutical Co Ltd focuses on three core values: innovation, integrity, and excellence. Their corporate philosophy revolves around contributing to society through the development and manufacturing of innovative and safe pharmaceutical products. By prioritizing ethical business practices and maintaining strict quality standards, Towa Pharmaceutical Co Ltd is dedicated to creating value for their customers, stakeholders, and the healthcare industry as a whole.

Towa Pharmaceutical Co Ltd is primarily present in Japan.

Towa Pharmaceutical Co Ltd has achieved several significant milestones throughout its history. Notably, the company has gained recognition for its strong portfolio of generic drugs, contributing to the improvement of global healthcare accessibility. Towa Pharmaceutical Co Ltd has also expanded its market presence through strategic collaborations and acquisitions, further strengthening its position in the pharmaceutical industry. Additionally, the company has consistently prioritized research and development, resulting in innovative products that address diverse medical needs. Towa Pharmaceutical Co Ltd has successfully established itself as a reputable and trusted name in the pharmaceutical sector, driving sustainable growth and delivering value to its stakeholders.

Founded in 1943, Towa Pharmaceutical Co Ltd is a renowned pharmaceutical company based in Japan. With over a century of expertise in the industry, Towa Pharmaceutical specializes in the research, development, and production of high-quality generic and branded medications. The company has built a strong reputation for its commitment to innovation, safety, and efficacy in its products. Towa Pharmaceutical consistently strives to improve global healthcare by providing affordable and accessible medical solutions. With a diverse product portfolio and a focus on customer satisfaction, Towa Pharmaceutical continues to be a trusted name in the pharmaceutical sector.

The main competitors of Towa Pharmaceutical Co Ltd in the market include Daiichi Sankyo Co Ltd, Eisai Co Ltd, and Astellas Pharma Inc.

Towa Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

The business model of Towa Pharmaceutical Co Ltd revolves around the development, manufacture, and sale of pharmaceutical products. As a leading company in the healthcare sector, Towa Pharmaceutical focuses on researching and producing innovative drugs that cater to various therapeutic areas. With a strong emphasis on quality control and adherence to regulatory standards, Towa Pharmaceutical ensures the safety and effectiveness of its medicines. By continuously investing in research and development activities, the company aims to contribute to advancements in healthcare and provide patients with access to reliable treatment options. Towa Pharmaceutical Co Ltd is dedicated to improving global healthcare through its pharmaceutical business.

Towa Pharmaceutical Co에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Towa Pharmaceutical Co에 대한 현재 KUV는 계산할 수 없습니다.

Towa Pharmaceutical Co에 대한 AlleAktien 품질 점수는 6/10입니다.

Towa Pharmaceutical Co 매출은 259.59 조. JPY입니다.

Towa Pharmaceutical Co 이익은 18.99 조. JPY입니다.

Towa Pharmaceutical Co Ltd is a Japanese pharmaceutical company that focuses on the development, manufacturing, and marketing of medicines. The company is divided into several business segments, namely pharmaceutical products, OTC products, and medical devices. The pharmaceutical segment of the company focuses on the development and manufacturing of prescription drugs for a variety of diseases such as cardiovascular diseases, diabetes, neurological disorders, infections, and cancer. The company has an extensive portfolio of drugs available as single agents or in combinations. Some of Towa Pharmaceutical's most well-known drugs include thrombolytics, memotropil, and loxoprofen. The OTC segment specializes in over-the-counter medicines that are available in pharmacies and drugstores. The company offers a variety of products aimed at improving the well-being and health of consumers. These include pain relievers, cough and cold medicines, vitamins and minerals, and smoking cessation products. Towa Pharmaceutical's medical device segment produces a range of devices for the diagnosis and treatment of various diseases. These include devices for measuring blood sugar, blood pressure, and cholesterol, electronic inhalers, and products for hemodialysis. Towa Pharmaceutical Co Ltd aims to develop and manufacture highly effective and high-quality products to improve the well-being and health of people worldwide. To achieve this, the company continuously invests in research and development to develop innovative technologies and products. Through a consistent focus on the quality, safety, and effectiveness of its products, the company has gained a good reputation in the global market. Towa Pharmaceutical's products are distributed in more than 30 countries worldwide. In summary, Towa Pharmaceutical Co Ltd offers a wide range of pharmaceutical products, OTC products, and medical devices. The company aims to develop and manufacture highly effective and high-quality products to improve the well-being and health of people worldwide. Through its investments in research and development and its consistent focus on quality, safety, and effectiveness, Towa Pharmaceutical has gained a good reputation in the global market.

Towa Pharmaceutical Co은(는) 연간 번의 배당을 통해 63 JPY의 배당금을 지급합니다.

Towa Pharmaceutical Co의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Towa Pharmaceutical Co의 ISIN은 JP3623150004입니다.

Towa Pharmaceutical Co의 WKN은 891725입니다.

Towa Pharmaceutical Co의 티커는 4553.T입니다.

지난 12개월 동안 Towa Pharmaceutical Co은(는) 40 JPY 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Towa Pharmaceutical Co은(는) 44.07 JPY의 배당금을 지급할 것으로 예상됩니다.

Towa Pharmaceutical Co의 현재 배당 수익률은 입니다.

Towa Pharmaceutical Co은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Towa Pharmaceutical Co은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 44.07 JPY의 배당금이 예상됩니다. 이는 배당수익률 1.34 %에 해당합니다.

Towa Pharmaceutical Co은 '건강' 섹터에 속합니다.

Towa Pharmaceutical Co의 마지막 배당금을 40 JPY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2024년에 Towa Pharmaceutical Co는 60 JPY를 배당금으로 지급했습니다.

Towa Pharmaceutical Co의 배당금은 JPY에 지급됩니다.